Protease inhibitor (EPIC-SR program)

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Protease inhibitor (EPIC-SR program), covering 2023-08-14 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). [Phase 2, Phase 3]